FDA Reconsiders "Morning-After" Pill for Over-the-Counter Status
FOR IMMEDIATE RELEASE
July 31, 2006 AMERICANS STRONGLY ENDORSE OVER-THE-COUNTER ACCESS TO THE ‘MORNING-AFTER’ PILL
FDA reconsiders application to widen access to Plan B as a result of public pressureSt. Paul - Robynne Curlee, Executive Director of Programs and Public Affairs at NARAL Pro-Choice Minnesota, released the following statement on the recent announcement by the Food and Drug Administration that it will reconsider an application by Barr Pharmaceuticals to approve the ‘morning-after’ pill, also known as Plan B®, for over-the-counter sales. “Americans are tired of the Bush administration playing politics and blocking women’s access to this effective form of birth control. Plan B® is proven to safely prevent unintended pregnancies, and it is critical that women have easy access to it in a timely manner to maxmize its effectiveness. We are cautiously optimistic that after more than three years of delays, sound science could prevail. The FDA needs to put women’s health before ideology, and approve the application for the ‘morning-after’ pill.” NARAL Pro-Choice Minnesota is an affiliate of NARAL Pro-Choice America, which has channeled tens of thousands of messages to the FDA. More than 5,000 hourglass timers and petitions have been delivered to their headquarters by NARAL Pro-Choice America supporters, asking the agency to end the three-year delay on approving the ‘morning-after’ pill for over the counter access.
Contact: Robynne Curlee, 651-602-7655
###
| 
